MedPath

Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast Cancer

Not Applicable
Completed
Conditions
Heart Injuries
Radiation Toxicity
Breast Neoplasms
Interventions
Radiation: free-breathing
Radiation: deep inspiratory breath-holding
Registration Number
NCT03461588
Lead Sponsor
Shu lian Wang
Brief Summary

This study is to prospectively investigate the cardiac dose-sparing effect and clinical benefit of deep inspiration breath-hold (DIBH) technique. Patients with left-sided breast cancer treated with breast conserving surgery followed by radiotherapy is enrolled. Radiotherapy is delivered with either free-breathing or deep inspiration breath-hold (DIBH) technique. The cardiac dose parameters and cardiac toxicity are prospective evaluated, and the dose-effect relationship is analyzed.

Detailed Description

Patients with left-sided breast cancer treated with breast conserving surgery are prospectively enrolled. Two types of radiation treatment are delivered based on attending physician's preferences: radiation to whole breast +- regional nodal areas with free-breathing technique, or with deep inspiration breath-hold (DIBH) technique. The cardiac dose parameters including heart dose and the dose to left anterior coronary artery are assessed, and the cardiac toxicities regularly assessed with cardiac enzymes,electrocardiogram(ECG) and normal gated single-photon emission computed tomography-myocardial perfusion imaging before, during and after radiation.The dose-effect relationship of heart injuries is analyzed.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
140
Inclusion Criteria
  1. Left-sided breast cancer
  2. Underwent breast conserving surgery
  3. Planned for postoperative whole breast +- regional nodal radiotherapy
  4. No basic heart disease
Exclusion Criteria
  1. Abnormal cardiac baseline examination
  2. History of chest radiation
  3. Can not tolerate deep inspiratory breath-holding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Free-breathingfree-breathingstandard treatment
Deep inspiratory breath-holdingdeep inspiratory breath-holdingnew technique
Primary Outcome Measures
NameTimeMethod
Number of participants with treatment-related cardiac adverse events as assessed by CTCAE v4.0up to 2 years

The cardiac adverse events are regularly assessed with cardiac symptoms,cardiac enzymes(TnT,BNP),electrocardiogram(ECG) and normal gated single-photon emission computed tomography-myocardial perfusion imaging.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Cancer Hospital, Chinese Academy of Medical Sciences

🇨🇳

Beijing, China

Cancer Hosptical, Chinese Academy of Medical Sciences

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath